9 5 6 3 1 2 4 10 8 7 1 Improbable — $502M, London 6 Babylon Health — $60M, London Entertainment software Healthcare services Series B Series B 2 Auto1 Group — $397.6M, Berlin 7 Valens — $60M, Hod Hasharon Automotive Semiconductors late-stage VC late-stage VC 3 GammaDelta Therapeutics — $100M, 8 Shadow —$56.3M, Paris London Computer parts Biotechnology early-stage VC early-stage VC BIMA (Mobile Micro-insurance) — 4 Actility — $75M, Paris 9 $55.2M, Stockholm Application software Insurance software Series D Series C 5 Iterum Therapeutics — $65M, Dublin 10 Algolia —$53M, Paris Drug discovery Automation software Series B Series B Source: Venture Pulse, Q2'17, Global Analysis of Venture Funding, KPMG Enterprise. Data provided by PitchBook, July 13, 2017. © 2017 KPMG International Cooperative (“KPMG International”). KPMG International provides no client services and is a Swiss entity with which the independent member firms of the KPMG network are affiliated. #Q2VC